Related Experiment Videos

Fulminant neonatal meningococcemia

Insights

Meningococcal disease is rare in infants due to maternal antibodies. A severe case of group B Neisseria meningitidis septicemia in a neonate was successfully treated, highlighting the need for consideration in infant sepsis cases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neonatology

Background:

  • Neisseria meningitidis infections are uncommon in infants under two months old, likely due to maternal antibody transfer.
  • Neonatal meningococcal disease typically presents with a milder clinical course in reported cases.

Observation:

  • A 25-day-old infant experienced severe meningococcemia caused by group B Neisseria meningitidis.
  • The infant survived this acute and severe presentation of the infection.

Findings:

  • Group B Neisseria meningitidis can cause severe septicemia in neonates.
  • Despite the severity, survival is possible with appropriate medical consideration.

Implications:

  • Clinicians should consider Neisseria meningitidis in neonates presenting with signs of septicemia.
  • The presence of cutaneous petechiae and purpura in a neonate with sepsis warrants investigation for meningococcal infection.

Related Concept Videos